Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

APOTEX

  • FDA Approval
  • Sept. 27, 2022, 02:31 UTC
  • 26
  • 0 comments

FDA approve LACOSAMIDE

Comment Full text

APOTEX

  • FDA Approval
  • Sept. 27, 2022, 02:31 UTC
  • 28
  • 0 comments

FDA approve GEFITINIB

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • Sept. 27, 2022, 02:31 UTC
  • 22
  • 0 comments

FDA approve DEFERASIROX

Comment Full text

RISING

  • FDA Approval
  • Sept. 27, 2022, 02:31 UTC
  • 26
  • 0 comments

FDA approve CAPECITABINE

Comment Full text

MYLAN

  • FDA Approval
  • Sept. 27, 2022, 02:31 UTC
  • 24
  • 0 comments

FDA approve ALFUZOSIN HYDROCHLORIDE

Comment Full text

RICONPHARMA LLC

  • FDA Approval
  • Sept. 27, 2022, 02:31 UTC
  • 28
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

LUPIN PHARMS

  • FDA Approval
  • Sept. 27, 2022, 02:31 UTC
  • 28
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

DR REDDYS

  • FDA Approval
  • Sept. 26, 2022, 21:03 UTC
  • 29
  • 0 comments

FDA approve TIMOLOL MALEATE

Comment Full text

MANKIND PHARMA

  • FDA Approval
  • Sept. 26, 2022, 21:03 UTC
  • 32
  • 0 comments

FDA approve TOBRAMYCIN

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • Sept. 26, 2022, 21:03 UTC
  • 29
  • 0 comments

FDA approve DEFERASIROX

Comment Full text
  • Previous
  • 980
  • 981
  • 982
  • 983
  • 984
  • Next

Search

News categories

  • Technical Exchange News(12342)
  • Event(6229)
  • SEC News(271554)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(157974)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin